Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
Title:
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
Author:
Loomba, Rohit Abdelmalek, Manal F Armstrong, Matthew J Jara, Maximilian Kjær, Mette Skalshøi Krarup, Niels Lawitz, Eric Ratziu, Vlad Sanyal, Arun J Schattenberg, Jörn M Newsome, Philip N
Appeared in:
The Lancet gastroenterology & hepatology
Paging:
Volume 8 () nr. 6 pages 511-522
Year:
2023
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license